ArticleJournal for immunotherapy of cancer2026

PLP1-triggered NOT gate to address neurotoxicity risk of PSMA-targeted prostate cancer therapy.

Sanam Shafaattalab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.